Self-serve medicine Pneumococcal vaccine doesn’t reduce cardiac risk A close shave reminds an MD to look beyond the obvious A history of cervical disc woes temporarily masks a new issue Reports of Guillain-Barré syndrome low after H1N1 vax Ontario surgeons say infection reporting rules unfair First IL-6 receptor inhibitor for rheumatoid arthritis Hoffmann-La Roche will soon be introducing Actemra (tocilizumab), the first interleukin-6 (IL-6) receptor inhibitor to be approved for the treatment of rheumatoid arthritis (RA). Antifungal clears nail infection Current treatment often fails to achieve a complete cure Vaccination fears and the ostrich technique persist Pregnant, new mom doctors need workplace support: report Pandemic H1N1 caused serious illness in transplant patients International study cites need for early antiviral therapy First Previous 617 618 619 620 621 Next Last
